(Q34149599)

31 July 2017

title

The pathogenesis of early retinal changes of diabetic retinopathy (English)

1 reference

31 July 2017

0 references

1

G B Arden

1 reference

31 July 2017

S Sivaprasad

2

1 reference

31 July 2017

publication date

1 February 2012

1 reference

Documenta Ophthalmologica

31 July 2017

published in

1 reference

31 July 2017

volume

124

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

15-26

1 reference

https://scigraph.springernature.com/pub.10.1007/s10633-011-9305-y

31 July 2017

exact match

0 references

cites work

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

A prospective randomized trial of intravitreal bevacizumab or laser therapy in the management of diabetic macular edema (BOLT study) 12-month data: report 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Free radicals in the physiological control of cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

The pathobiology of diabetic complications: a unifying mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Vascular damage in a mouse model of diabetic retinopathy: relation to neuronal and glial changes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Capillary lesions develop in retina rather than cerebral cortex in diabetes and experimental galactosemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

THE EFFECTS OF VARIATIONS IN THE CONCENTRATION OF OXYGEN AND OF GLUCOSE ON DARK ADAPTATION.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

ANOXIA AND BRIGHTNESS DISCRIMINATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

II. Improved dark adaptation after carotid endarterectomy. Evidence of a long-term ischemic penumbra?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

I. Impaired dark adaptation in symptomatic carotid artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Impaired dark adaptation in polycythemia. Improvement after treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Effects of light and darkness on oxygen distribution and consumption in the cat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Diabetic retinopathy: early functional changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Oxygen distribution and consumption in the macaque retina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Dark Current and Photocurrent in Retinal Rods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Molecular mechanisms of vertebrate photoreceptor light adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Transduction heats in retinal rods: tests of the role of cGMP by pyroelectric calorimetry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Rod photoreceptor loss in Rho-/- mice reduces retinal hypoxia and hypoxia-regulated gene expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Choriocapillaris degeneration and related pathologic changes in human diabetic eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Blood-brain barrier integrity is unaltered in human brain cortex with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Does occupational exposure to argon laser radiation decrease colour contrast sensitivity in UK ophthalmologists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Hyperoxia improves contrast sensitivity in early diabetic retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Effect of darkness on inner retinal hypoxia in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Electrophysiological changes in juvenile diabetics without retinopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Partial reversal of protan and tritan colour defects with inhaled oxygen in insulin dependent diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Retinal blood flow in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Effect of acute hyperglycemia on oxygen and oxidative metabolism in the intact cat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

The absence of diabetic retinopathy in patients with retinitis pigmentosa: implications for pathophysiology and possible treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Ocular oxygenation and the treatment of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Laser-induced changes in intraretinal oxygen distribution in pigmented rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Relationship between diabetic retinopathy and sleep-disordered breathing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

The prevalence of retinopathy in men with Type 2 diabetes and obstructive sleep apnoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

The association between obstructive sleep apnea syndrome and microvascular complications in well-controlled diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Anti-inflammatory and antioxidant effects of SERPINA3K in the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Immunological mechanisms in the pathogenesis of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Impact of variants in the VEGF gene on progression of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

VEGF Polymorphisms Are Associated with Severity of Diabetic Retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Spare the rod and spoil the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Vascular endothelial growth factor and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Assessment of selected adhesion molecule and proinflammatory cytokine levels in the vitreous body of patients with type 2 diabetes--role of the inflammatory-immune process in the pathogenesis of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Vitreous fluid of db/db mice exhibits alterations in angiogenic and metabolic factors consistent with early diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Increased H2O2, vascular endothelial growth factor and receptors in the retina of the BBZ/Wor diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

A review of clinical trials of anti-VEGF agents for diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Intravitreous anti-VEGF for diabetic retinopathy: hopes and fears for a new therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Anti-vascular endothelial growth factor agents for diabetic maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Treatment of diabetic retinopathy with anti-VEGF drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

The influence of glucose concentration and hypoxia on VEGF secretion by cultured retinal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

The Optic UK Lecture: bench-to-bedside adventures of a diabetes researcher: results past, results present

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Hypoxic induction of vascular endothelial growth factor is markedly decreased in diabetic individuals who do not develop retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Supplemental oxygen improves diabetic macular edema: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

A preliminary trial to determine whether prevention of dark adaptation affects the course of early diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10633-011-9305-Y

Oxygen Tension and Blood Flow in the Retina of Normal and Diabetic Rats

21 January 2018

1 reference

12 December 2020

Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascularization

1 reference

12 December 2020

Cytokine profile of peripheral blood in type 2 diabetes mellitus patients with diabetic retinopathy.

1 reference

12 December 2020

Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy

1 reference

12 December 2020

Correction of early subnormal superior hemiretinal DeltaPO(2) predicts therapeutic efficacy in experimental diabetic retinopathy.

1 reference

12 December 2020

Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin

1 reference

12 December 2020

Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group

1 reference

12 December 2020

Regression of early diabetic macular oedema is associated with prevention of dark adaptation

1 reference

12 December 2020

Does mitochondrial genome mutation in subjects with maternally inherited diabetes and deafness decrease severity of diabetic retinopathy?

1 reference

12 December 2020

Oxygen consumption in the inner and outer retina of the cat.

1 reference

12 December 2020

Early retinopathy progression in four randomized trials comparing insulin glargine and NPH [corrected] insulin.

1 reference

12 December 2020

Retinal hypoxia in long-term diabetic cats

1 reference

12 December 2020

Retinitis pigmentosa and retinal neovascularization

1 reference

12 December 2020

Oxidative stress and diabetic retinopathy

1 reference

12 December 2020

Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration

1 reference

12 December 2020

Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy

1 reference

12 December 2020

Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor

1 reference

12 December 2020

Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels

1 reference

12 December 2020

Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products

1 reference

12 December 2020

Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retino

1 reference

12 December 2020

The energetic cost of photoreception in retinal rods of mammals

1 reference

12 December 2020

Role of NADPH oxidase and ANG II in diabetes-induced retinal leukostasis

1 reference

12 December 2020

Glial reactivity, an early feature of diabetic retinopathy.

1 reference

12 December 2020

10.1007/S10633-011-9305-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1032532507

0 references

1 reference